Suppr超能文献

Managing adverse events of multiple myeloma and anti-multiple myeloma treatment: a perspective on carfilzomib.

作者信息

Siegel David S

出版信息

Oncology (Williston Park). 2013 Dec;27 Suppl 3:2-3.

Abstract
摘要

相似文献

3
Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma.
J Oncol Pharm Pract. 2013 Dec;19(4):348-54. doi: 10.1177/1078155212470388. Epub 2013 Jan 4.
6
Carfilzomib: a novel agent for multiple myeloma.
J Pharm Pharmacol. 2013 Aug;65(8):1095-106. doi: 10.1111/jphp.12072. Epub 2013 Apr 24.
7
Management of Carfilzomib-Associated Cardiac Adverse Events.
Clin Lymphoma Myeloma Leuk. 2016 May;16(5):241-5. doi: 10.1016/j.clml.2016.01.008. Epub 2016 Feb 4.
8
Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple Myeloma.
Intern Med. 2019 Jun 1;58(11):1577-1581. doi: 10.2169/internalmedicine.2194-18. Epub 2019 Feb 1.
10
Carfilzomib: a second-generation proteasome inhibitor for the treatment of relapsed and refractory multiple myeloma.
Ann Pharmacother. 2013 Jan;47(1):56-62. doi: 10.1345/aph.1R561. Epub 2013 Jan 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验